In last trading session, Tandem Diabetes Care Inc (NASDAQ:TNDM) saw 1.06 million shares changing hands with its beta currently measuring 1.51. Company’s recent per share price level of $19.11 trading at -$0.31 or -1.60% at ring of the bell on the day assigns it a market valuation of $1.27B. That closing price of TNDM’s stock is at a discount of -152.43% from its 52-week high price of $48.24 and is indicating a premium of 17.58% from its 52-week low price of $15.75. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 1.24 million shares which gives us an average trading volume of 1.52 million if we extend that period to 3-months.
For Tandem Diabetes Care Inc (TNDM), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 2.20. Splitting up the data highlights that, out of 10 analysts covering the stock, 1 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 1 suggested the stock as a Hold whereas 8 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
Tandem Diabetes Care Inc (NASDAQ:TNDM) trade information
Upright in the red during last session for losing -1.60%, in the last five days TNDM remained trading in the red while hitting it’s week-highest on Tuesday, 06/24/25 when the stock touched $19.11 price level, adding 9.77% to its value on the day. Tandem Diabetes Care Inc’s shares saw a change of -52.20% in year-to-date performance and have moved -6.35% in past 5-day. Tandem Diabetes Care Inc (NASDAQ:TNDM) showed a performance of -11.03% in past 30-days. Number of shares sold short was 8.82 million shares which calculate 6.31 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 25 to the stock, which implies a rise of 23.56% to its current value. Analysts have been projecting 22 as a low price target for the stock while placing it at a high target of 53. It follows that stock’s current price would drop -15.12% in reaching the projected high whereas dropping to the targeted low would mean a loss of -15.12% for stock’s current value.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -28.23% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 5.91% while estimates for its earnings growth in next 5 years are of 71.00%.
Tandem Diabetes Care Inc (NASDAQ:TNDM)’s Major holders
Insiders are in possession of 0.94% of company’s total shares while institution are holding 111.67 percent of that, with stock having share float percentage of 112.73%. Investors also watch the number of corporate investors in a company very closely, which is 111.67% institutions for Tandem Diabetes Care Inc that are currently holding shares of the company. BLACKROCK INC. is the top institutional holder at TNDM for having 11.12 million shares of worth $448.14 million. And as of 2024-06-30, it was holding 17.1137 of the company’s outstanding shares.
The second largest institutional holder is VANGUARD GROUP INC, which was holding about 7.38 million shares on 2024-06-30. The number of shares represents firm’s hold over 11.3518 of outstanding shares, having a total worth of $297.26 million.
